To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...

A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval.

The panel had become a flashpoint as RFK Jr.'s health department worked to limit the number of recommended childhood shots.

The Justice Department's actions on illegal vapes pales next to the scale of the problem, anti-smoking advocates say.

In my most honest of moments, what I want from the medical community is the chance to trust it again,” a MAHA advocate writes ...

The Trump administration this week acknowledged it made a significant error in figures it used to help justify a fraud ...

At a national public health meeting in March, I attended a session that brought together public health professionals, ...

The taxes are part of the president's push to rein in the pharmaceutical industry and bring manufacturing to the U.S.

Matthew Herper covers medical innovation — both its promise and its perils. An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...

The Trump administration will not be asking the Supreme Court to take up its fight to slash NIH support for research indirect ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Zac Jiwa, a federal Medicare ...

WASHINGTON — The Trump administration has prepared an order that would impose a 100% tariff on imports of patented ...